Multi-Center Study of Panosyl-Isomaltooligosaccharides Adjunctive to PPI Therapy to Treat GERD
- First Posted Date
- 2022-09-27
- Last Posted Date
- 2025-05-28
- Lead Sponsor
- Microbiome Health Sciences
- Target Recruit Count
- 156
- Registration Number
- NCT05556824
- Locations
- ๐บ๐ธ
Elite Clinical Studies LLC, Phoenix, Arizona, United States
๐บ๐ธWr-Msra, Llc, Lake City, Florida, United States
๐บ๐ธA Positive Clinical Research, Miami, Florida, United States
Tolerability Study of Panosyl-Isomaltooligosaccharides (PIMO) and a Placebo in Subjects With Heartburn
Not Applicable
Completed
- Conditions
- Heartburn
- Interventions
- Dietary Supplement: Panosyl-isomaltooligosaccharides (PIMO) 1g (1.4 ml)Other: Placebo 1.4 ml
- First Posted Date
- 2022-05-06
- Last Posted Date
- 2023-07-18
- Lead Sponsor
- Microbiome Health Sciences
- Target Recruit Count
- 211
- Registration Number
- NCT05363618
- Locations
- ๐บ๐ธ
Microbiome Health Sciences, Manassas, Virginia, United States
Tolerability Study of Panosyl Isomaltooligosaccharides (PIMO), in Subjects With Chronic Idiopathic Constipation (CIC)
Not Applicable
Completed
- Conditions
- Constipation Chronic Idiopathic
- Interventions
- Dietary Supplement: MHS 1031Other: placebo
- First Posted Date
- 2021-11-22
- Last Posted Date
- 2023-07-18
- Lead Sponsor
- Microbiome Health Sciences
- Target Recruit Count
- 172
- Registration Number
- NCT05129618
- Locations
- ๐บ๐ธ
Remote Study - by phone and online, Manassas, Virginia, United States
Open Label Tolerability Study of ISOThrive Prebiotic Nectar (MIMO) in Subjects With Constipation
Not Applicable
Completed
- Conditions
- Constipation
- Interventions
- Dietary Supplement: ISOThrive Prebiotic Nectar
- First Posted Date
- 2020-12-21
- Last Posted Date
- 2022-05-05
- Lead Sponsor
- ISOThrive Inc.
- Target Recruit Count
- 106
- Registration Number
- NCT04677634
- Locations
- ๐บ๐ธ
ISOThrive Inc., Manassas, Virginia, United States
Tolerability Study of a Novel Microbiome Therapeutic in Subjects With Gastroesophageal Reflux Disease
Not Applicable
Completed
- Conditions
- Gastroesophageal Reflux
- Interventions
- Dietary Supplement: maltosyl-isomalto-oligosaccharides (MIMO)
- First Posted Date
- 2020-07-29
- Last Posted Date
- 2021-08-30
- Lead Sponsor
- ISOThrive Inc.
- Target Recruit Count
- 156
- Registration Number
- NCT04491734
- Locations
- ๐บ๐ธ
ISOThrive Inc., Manassas, Virginia, United States